Status:
COMPLETED
Non-interventional Study Related to Fixed LAMA/LABA/ICS Triple Therapy
Lead Sponsor:
Chiesi UK
Collaborating Sponsors:
Liverpool Heart and Chest Hospital NHS Foundation Trust
Conditions:
COPD
Eligibility:
All Genders
35-100 years
Brief Summary
This is a prospective non-interventional trial to measure the health related quality of life of patients with chronic obstructive pulmonary disease (COPD) on a fixed LAMA/LABA/ICS triple therapy (Trim...
Detailed Description
The primary goal of COPD therapy is the prevention of exacerbations and clinical deterioration. To achieve these goals, treatment adherence (i.e. taking medication as prescribed) is important. However...
Eligibility Criteria
Inclusion
- Patients with moderate to severe COPD (with and without concomitant asthma)
- Physician decision to start therapy with Trimbow as per its current marketing authorisation; the treatment decision should be made independently from participation in this Non-Interventional Trial
- Patients with at least one COPD exacerbation within the previous 12 months
- Patients willing and able to sign informed consent for use of their pseudonymised clinical data within the present Non-Interventional Trial
Exclusion
- Patients hospitalised due to an exacerbation of their COPD within the last 4 weeks prior to enrolment
- Participation within an interventional clinical trial within 30 days prior to enrolment into the present Non-Interventional Trial
Key Trial Info
Start Date :
July 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 9 2022
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04355546
Start Date
July 15 2020
End Date
June 9 2022
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liverpool Heart and Chest Foundation Trust
Liverpool, United Kingdom, L14 3PE